SPRIM Global Investments, established in 2008, is a venture capital fund focused on Series B biotech companies. Leveraging SPRIM Consulting & Services' extensive network, they source, screen, and select high-potential startups, offering financial support and strategic guidance. Notable investments include Stalicla. The fund aims to accelerate the growth of innovative health solutions by supporting dynamic young enterprises.
